Ciclindole

Ciclindole ( ; developmental code name WIN-27,147-2), also known as cyclindole ( ), is an antipsychotic of the tetrahydrocarbazolamine family with a tricyclic cyclized tryptamine structure that was never marketed.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Ciclindole ( ; developmental code name WIN-27,147-2), also known as cyclindole ( ), is an antipsychotic of the tetrahydrocarbazolamine family with a tricyclic cyclized tryptamine structure that was never marketed. It displaces spiperone binding in vitro and elevates dopamine levels in the striatum, indicating that it acts as a dopamine D 2 receptor antagonist.

It also shows apparent affinity for the α 1 -adrenergic receptor, the serotonin S 1 receptor, and the serotonin S 2 receptor. However, its affinities for all of the preceding targets are weak, in the low micromolar range. The related drug flucindole is about 5 to 10 times more potent than ciclindole both in vitro and in vivo.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1338609945 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.